Galanthamine CAS: 357-70-0

CAS NO: 357-70-0
Galanthamine
Chemical Name: Galanthamine
Molecular Formula: C17H21NO3
Formula Weight: 287.35
CAS No.: 357-70-0
Description Review
Description

Galanthamine is a potent alkaloid derived from snowdrop plants. It acts as a cholinesterase inhibitor and has been used for long-term treatment of both central and peripheral cholinergically dependent conditions. It has been extensively studied over the years, and this article seeks to provide detailed information on this product, including its chemical formula, benefits, effects, mechanism, safety, side effects and dosing information.

Chemical name Galanthamine's chemical name is (4aS,6R,8aS)-5,6,9,10-Tetramethoxy-4a,5,6,7,8,8a-hexahydro-3aH-benzazepino[3,2-d][1,3]dioxol-6-ol.

Molecular formula The molecular formula of Galanthamine is C17H21NO3.

Formula weight The formula weight of Galanthamine is 287.36 g/mol.

CAS No The CAS number of Galanthamine is 357-70-0.

Top ten keywords from Google and synonyms

  1. Memory enhancement
  2. Alzheimer’s disease
  3. Cholinesterase inhibitor
  4. Acetylcholine
  5. Galantamine Hydrobromide
  6. Parkinson’s disease
  7. Cognition
  8. Nootropics
  9. Neurodegeneration
  10. Dementia

Synonyms include Galantamine Hydrobromide, Galantamine HBr, Nivalin, Nivalin Hydrobromide, Lycoremine, Galantaminum.

Health benefits of Galanthamine Galanthamine has a number of health benefits due to its ability to inhibit acetylcholinesterase, which is responsible for breaking down acetylcholine. Some of the health benefits of Galanthamine are:

  1. Treatment of Alzheimer's disease: Galanthamine is a medication that is widely used in the treatment of Alzheimer's disease. It is effective in improving cognitive function and slowing down the progression of the disease.

  2. Improvement of memory and learning: Galanthamine improves memory and learning in both healthy individuals and those with Alzheimer's disease. It helps to improve the speed of recall and the ability to retain information.

  3. Treatment of Parkinson's disease: Galanthamine has been shown to improve motor function in Parkinson's disease patients.

  4. Treatment of myasthenia gravis: Galanthamine is effective in the treatment of myasthenia gravis, a neuromuscular disorder that causes muscle weakness.

Potential effects of Galanthamine Galanthamine has a number of potential effects due to its ability to increase the levels of acetylcholine in the brain. Some of the potential effects of Galanthamine are:

  1. Improved attention and focus: Galanthamine improves attention and focus by increasing the activation of the prefrontal cortex.

  2. Improved mood: Galanthamine has been shown to improve mood and reduce symptoms of depression and anxiety.

  3. Increased alertness: Galanthamine increases alertness by improving the function of the brain.

Product mechanism Galanthamine works by inhibiting the activity of acetylcholinesterase, an enzyme that breaks down acetylcholine, a neurotransmitter that is important for learning and memory. By inhibiting the activity of acetylcholinesterase, Galanthamine increases the levels of acetylcholine in the brain, leading to improvements in cognitive function.

Safety of Galanthamine Galanthamine is generally safe when taken in recommended doses. However, it can cause side effects, and should not be taken without consulting a healthcare professional. Moreover, patients with certain medical conditions, such as liver or kidney disease, should not take this medication.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code